Comparator Drugs in Clinical Trial Logistics: Oversight and Compliance
Comparator Drugs in Clinical Trial Logistics: Oversight and Compliance Managing Comparator Drugs in Clinical Trial Logistics Introduction: Why Comparator Drugs Pose Unique Challenges Comparator drugs are critical for many Phase II and III clinical trials where investigational products are evaluated against standard-of-care or placebo-controlled arms. Unlike investigational medicinal products (IMPs) manufactured under sponsor control, comparators…
Read More “Comparator Drugs in Clinical Trial Logistics: Oversight and Compliance” »